PSY62 PERCEIVED BENEFITS AND DISADVANTAGES OF INTRAVENOUS (IV) BIOLOGIC THERAPY AMONG PATIENTS WITH IMMUNOLOGY CONDITIONS

May 1, 2011, 00:00 AM
10.1016/j.jval.2011.02.394
https://www.valueinhealthjournal.com/article/S1098-3015(11)00533-X/fulltext
Section Title : Disease-Specific Studies
Section Order : 956
First Page : A70
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)00533-X&doi=10.1016/j.jval.2011.02.394
HEOR Topics :
Tags :
Regions :